who manufactures glp-1 drugs Market Trends and Global Forecasts Report 2025: A Patients' Use GLP-1 Drugs for

There are only a few published cases of semaglutide use in PWS, usually in the setting of concomitant diabetes using doses of 0.5 and 1 mg weekly, with limited evidence on the long-term efficacy and safety of semaglutide in PWS without diabetes

It is possible that some of those patients were in honeymoon period, or had an alternative diagnosis, such as ketosis-prone diabetes or latent autoimmune diabetes in adults (LADA)

Diabetes and GLP-1 RA Use in Cancer Incidence Beyond weight loss, GLP-1 RAs appear to have a protective effect against cancer development and progression

The sodium salt is probably effective, but thats not how it was tested to gain FDA-approval

[DOI] [PMC free article] [PubMed] [Google Scholar] 93.Heerspink H.J.L., Perco P., Mulder S., Leierer J., Hansen M.K., Heinzel A., Mayer G